STEMI randomly assigned to thrombus aspiration or conventional primary PCI group before coronary angiography. The primary endpoint was defined as a significant reduction of IMR in thrombus aspiration compared to conventional PCI group. Myocardial perfusion grade and resolution of ST-segment elevation were also assessed. Infarct size and left ventricle remodeling were assessed by echocardiographic indices and SPECT. Results: Manual thrombus aspiration, as compared with conventional PCI, resulted in significantly lower IMR (31.9AE21.3 U vs. 47.0AE35.8 U, P ¼ 0.0082). Treatment with thrombus aspiration, as compared with conventional PCI, resulted in similar rates of myocardial perfusion grade 0 or 1 (20.8% vs. 29.4%; relative risk, 0.71; 95% CI, 0.38 to 1.30; P¼0.26) and complete resolution of ST-segment elevation (59.7% vs. 47.1%; relative risk, 1.27; 95% CI, 0.90 to 1.79, P¼0.17). In a multiple regression model with the log-transformed IMR as dependent variable, after adjusting for clinical, angiographic and procedural variables, thrombus aspiration remained a strong independent predictor of lower IMR (27.14 U; 95% CI, 23.79 to 30.95 U, vs. 36.11 U; 95% CI, 30.74 to 42.41 U, P¼0.0076). Histopathological examination confirmed successful thrombus aspiration in 89.6% of patients. Conclusions: Manual thrombus aspiration reduces microcirculatory resistance indicating better myocardial perfusion compared to conventional PCI in patients with STEMI. Manual thrombus aspiration tended towards improved clinical outcome.
TCT-142
Thrombus aspiration is similarly effective in STEMI patients with ischemia lasting less than 6 hours compared to those with longer ischemia: subanalysis of the PATA STEMI trial Medical School University of Belgrade, University City Hospital "Zvezdara" Belgrade, Belgrade, Serbia and Montenegro Background: It has been reported that thrombus aspiration is effective in STEMI patients with total ischemic time duration of less than 3 hours and less effective in longer ischemia. Some studies tested thrombus aspiration efficacy only within 6 hours from chest pain onset. However, little is known about invasive assessment of thrombus aspiration efficacy in STEMI patients beyond 6 hours of ischemia. Methods: Patients who underwent thrombus aspiration were divided into two groups according to total ischemic time duration: < 6 hours and !6 hours. These patients were taken from the PATA STEMI trial for the analysis. Primary endpoint was value of mean index of microcirculatory resistance (IMR). Secondary endpoints were myocardial blush grade (MBG), resolution of ST segment elevation, AUC CK, wall motion score index (WMSI), left ventricular ejection fraction and MACE rate at one year follow-up. Results: In the PATA STEMI trial 75 patients underwent manual thrombus aspiration with the Eliminate3 catheter (Terumo Europe, Leiden, Belgium). In baseline characteristics, patients delay (74,5 vs 377,9, P¼0,00018) and multivessel disease (46,0% vs 83,3%, P¼0,026) were more frequent in patients with total ischemic time !6 hours (N¼12). In patients with totals ischemic time < 6 hours (N¼63) compared to those with !6 hours, mean IMR was 30 Background: It has been reported that index of microcirculatory resistance (IMR) is lower in STEMI patients who underwent thrombus aspiration before stent implantation compared to those tretaed with conventional primary PCI. The aim of this study was to evaluate impact of improved myocardial perfusion by manual thrombus aspiration assessed by IMR on left ventricular remodeling in STEMI patients at mid-term follow-up. Methods: The total of 115 patients entered the echocardiography substudy of the PATA STEMI (randomized Physiologic Assessment of Thrombus Aspirtion in patients with ST-segment Elevation Myocardial Infarction) trial which evaluated eficacy of manual thrombus aspiration using Eliminate3 catheter (Terumo Europe, Leuven, Belgium). Echocardiography was done within the first 24 hours after the index procedure and after 4 months. End-diastolic and end-systolic left ventricular (LV) volumes, ejection fraction (EF), cardiac sphericity index (CSI) and regional wall motion score index (WMSI) were calculated. Results: In baseline characteristics, in patients with thrombus aspiration compared to those with conventional primary PCI, total ischemic time tended to be longer 246,7AE181,8 vs. 200,9AE110,1 min, P¼0,09 and AUC CK was smaller 40090AE26158 U/L vs. 52676AE32013 U/L, P¼0,026. Also, corrected IMR was lower in thrombus aspiration group 27,5AE16,8 vs. 39,9AE32,7 U/L, p¼0,0079, while CFR (1,68AE0,81 vs. 1,61AE0,67, P¼0,6) and mean capilary wedge pressure (20,4AE6,6 vs. 21,4AE7,8 mmHg, P¼0,5) were similar. End-diastolic and end-systolic LV volumes per body surface area, EF, CSI volume and WMSI were similar between the thrombus aspiration and no aspiration group at baseline and at follow-up. At follow-up, percent change in WMSI tended to be greater in thrombus aspiration group (decrease in WMSI 8,2% vs. increase in WMSI 0,8%, P¼0,094). Conclusions: Improved myocardial perfusion assessed by IMR has no impact on left ventricular remodeling in STEMI patients at mid-term follow-up.
TCT-144
The clinical efficacy of thrombus aspiration on five-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention Kyoto University, Kyoto, Japan
Background: The use of adjunctive thrombus aspiration (TA) promotes better coronary reperfusion and improves myocardial perfusion in STEMI but the long-term mortality benefit still remains controversial. Methods: The CREDO-Kyoto AMI registry is a large-scale cohort study of acute myocardial infarction (AMI) patients undergoing coronary revascularization in 2005-2007 at 26 hospitals in Japan. Among 5429 patients enrolled in the registry, the current study population consisted of 3325 patients who arrived at the hospital within 12 hours after the symptom onset and underwent primary PCI. During primary PCI, 2120 out of 3325 (63.8%) patients received thrombus aspiration (the TA group). Clinical outcomes were compared between the TA group and the non-TA group. Results: The cumulative five-year incidence of all-cause death was significantly lower in the TA group than in the non-TA group (18.6% versus 22.6%, P< 0.001). Similarly, the cumulative incidences of cardiac death, non-cardiac death, and target-lesion revascularization (TLR) were significantly lower in the TA group. After adjusting for confounders, however, the use of adjunctive TA was not associated with lower risk for all-cause death (hazard ratio www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM-7:00 PM Background: Radiation exposure is associated with increased risk of malignancies and cataract formation. Recent case series of predominantly left sided brain malignancies in interventional cardiologists suggest an increased risk with long term exposure to occupational radiation. These data suggest that further measures to protect healthcare workers are needed. We aimed to evaluate the efficacy of two novel shields in reducing interventional cardiologists' radiation exposure during angiographic procedures. Methods: We conducted a prospective, randomized, controlled clinical trial with enrollment of 230 patients undergoing coronary angiography or percutaneous coronary intervention from November 2013 to May 2014. Patients were randomized to have their procedure performed with or without placement of a pelvic lead shield designed for either radial or femoral access, and designed to reduce radiation scatter. During all procedures, an interventional cardiologist was fitted with a novel, paper thin, non-lead surgical cap (No Brainer, RADPAD, weight 53 grams) to protect the brain from radiation exposure. The co-primary outcomes for the lead shield comparison was i) the difference between both groups in total operator radiation dose (mSv) at the left chest level and ii) the difference between groups in operator dose divided by Air Kerma (mSv/mGy). For the cap comparison, the primary outcome was the difference between total radiation dose (mSv) as measured by two dosimeters at left temporal region of the head of the interventional cardiologist (one on the outside of the cap and the other one on the inside of it). Radiation dose was measured using Unfors Educational Direct Dosimeters (EDD-30).
Results: The full results of the study will be available at time of presentation. Conclusions: The RADIATION PROTECT study will help determine the efficacy of a novel lead shield and a novel non-lead surgical cap for reducing operator radiation exposure during coronary angiography or intervention.
TCT-146
Patient Ghent University, Ghent, Belgium
Background: During interventional cardiology procedures patient and staff are exposed to X-ray radiation. Minimizing radiation dose is a crucial part of quality care. This study quantifies the radiation dose reduction for patient and staff enabled by a novel X-ray imaging technology using advanced real-time image noise reduction algorithms and an optimized acquisition chain (AlluraClarity, Philips Healthcare, The Netherlands). First results are reported. Methods: Between March-May 2014, 48 patients referred for coronary angiography and angioplasty were prospectively scheduled and randomized for room A (FD10 monoplane system with state of the art image processing and reference acquisition chain) or room B (FD2010 biplane system with the novel imaging technology) in a 1:2 ratio. Patients' demographics and procedure characteristics were recorded; exposure parameters from all planes were logged via DICOM SR. Scatter dose is quantified by a dosimeter placed on the C-arc, at a fixed position, not affected by any shielding device. Occupational dose is quantified by dosimeters placed on the torso and leg of physicians and logged via DICOM SR (DoseAware Xtend, Philips Healthcare, Best, The Netherlands).
Results: Demographic data, exposure parameters and occupational doses are summarized in Table 1 , showing comparable patient demographics and procedure complexity for room A and B. DAP values for fluoroscopy and exposure decreased with 33% and 75%, respectively. Scatter dose decreased with 67% in room B for the C-arc dosimeter and 53% for the physician leg. However, physician torso dose (less than 35% of leg dose) did not differ significantly. This needs to be further investigated.
Conclusions:
The novel X-ray imaging technology resulted in a significant and substantial patient and occupational dose reduction, without affecting patient and procedure characteristics.
TCT-147
Patient radiation exposure with a novel X-ray imaging technology during coronary angiography and angioplasty 
